SCHEMBL13899403

SCHEMBL13899403

Cc1ccc(-c2nc(CCC(C)C)no2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 7/20 0.51
RAB9A P51151 7/20 0.51
SMN1; SMN2 Q16637 4/20 0.51
MAPT P10636 3/20 0.51
ALDH1A1 P00352 2/20 0.51
PKM P14618 2/20 0.51
KDM4E B2RXH2 1/20 0.51
HPGD P15428 1/20 0.51
HSD17B10 Q99714 1/20 0.51
MAPK1 P28482 2/20 0.51
L3MBTL1 Q9Y468 2/20 0.51
MAOA P21397 2/20 0.48
MAOB P27338 2/20 0.48
NFKB1 P19838 3/20 0.47
NFKB2 Q00653 3/20 0.47
RELA Q04206 3/20 0.47
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
NR1H4 Q96RI1 1/20 0.46
NPSR1 Q6W5P4 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13906032 0.82 NPC1 (0.73) NPC1RAB9ASMN1; SMN2MAPTALDH1A1
SCHEMBL13899565 0.79 PPARG (0.52) NPC1RAB9ASMN1; SMN2MAPTALDH1A1
SCHEMBL10053916 0.78 MAPT (0.57) NPC1RAB9ASMN1; SMN2MAPTALDH1A1
SCHEMBL12071899 0.78 L3MBTL1 (0.57) NPC1RAB9ASMN1; SMN2MAPTALDH1A1
SCHEMBL843409 0.76 MAPT (0.49) NPC1RAB9ASMN1; SMN2MAPTALDH1A1
SCHEMBL5952948 0.74 ACHE (0.71) NPC1RAB9ASMN1; SMN2MAPTALDH1A1
SCHEMBL12125439 0.72 NR2F2 (0.42) RAB9AALDH1A1KDM4EL3MBTL1MEN1
SCHEMBL10094547 0.71 MAOA (0.57) NPC1RAB9ASMN1; SMN2MAPTALDH1A1
SCHEMBL12267148 0.70 NPC1 (0.85) NPC1RAB9ASMN1; SMN2MAPTALDH1A1
SCHEMBL16649050 0.70 PPARG (0.48) NPC1RAB9ASMN1; SMN2MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7507757-B2 Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method BRISTOL-MYERS SQUIBB COMPANY (US) 2009-03-24 US disclosed